ASX:PKYSoftware & ServicesApplication Software
Pathkey.AI Ltd
$0.031
$0.007 (18.42%)
Day Range
$0.031 – $0.035
52 Week Range
$0.013 – $0.075
Volume
4.05M
Avg Volume (10D)
6.22M
Market Cap
$38.53M
Price Chart
Market Statistics
Open$0.035
Previous Close$0.038
Day High$0.035
Day Low$0.031
52 Week High$0.075
52 Week Low$0.013
Valuation
Market Cap38.53M
Shares Outstanding1.24B
Price to Book20.92
Trading Activity
Volume4.05M
Value Traded133.44K
Bid$0.031 × 241,767
Ask$0.036 × 85,714
Performance
1 Day-18.42%
5 Day-20.51%
13 Week-16.22%
52 Week37.24%
YTD93.75%
Technical Indicators
RSI (14)31.28
50-Day SMA$0.048
200-Day SMA$0.030
Latest News
Technology
Pathkey.AI Moves to Add Semiconductor Design Platform through Chipforge Acquisition
Pathkey.AI to acquire Chipforge, expanding AI into semiconductor design; irrevocable option to buy 100% within 2 months, via 560 million Pathkey shares.
Technology
Pathkey.AI Lands Largest Contract Yet for TrialKey Platform with Imunexus Therapeutics
Pathkey.AI lands its biggest deal yet with Imunexus for TrialKey, up to $100k (incl. $25k upfront); remainder tied to capital raises—1-year pact.
Technology
Pathkey.AI Validates TrialKey With Strong Alignment To Clinical Outcomes
Pathkey.AI (ASX: PKY) has unveiled its first validation study of the TrialKey platform, an AI tool to predict clinical trial success. The company reported that TrialKey correctly aligned with 73% of trial outcomes across 11 clinical programs that reported results between March and July 2025. Management said the findings mark a critical step in proving […]